Precision BioSciences Announces Appointment Of Gene Liau, Ph.D. And Bruce Mccreedy, Ph.D. To Management Team
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences, the genome editing company, today announced two key additions to the executive team - Gene Liau, Ph.D., as Senior Vice President, Gene Therapy and Bruce McCreedy, Ph.D., as Senior Vice President, Cell Therapy.
“We are excited to welcome Gene and Bruce to the Precision team,” said Matthew Kane, Chief Executive Officer of Precision BioSciences. “Their proven leadership and breadth of experience will undoubtedly prove critical to our gene and cell therapy product development programs.
Help employers find you! Check out all the jobs and post your resume.
“We are excited to welcome Gene and Bruce to the Precision team,” said Matthew Kane, Chief Executive Officer of Precision BioSciences. “Their proven leadership and breadth of experience will undoubtedly prove critical to our gene and cell therapy product development programs.
Help employers find you! Check out all the jobs and post your resume.